Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01622153 · ClinicalTrials.gov registry record · NA
Electrical and Formocresol Pulpotomy in Primary Molars
A NA study, sponsored by University Hospitals Cleveland Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 120
- Enrollment target
NCT01622153: Clinical Trial NA study, sponsored by University Hospitals Cleveland Medical Center.
NCT01622153 is a NA study that was terminated before completion, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 120 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01622153, a NA study, was terminated before completion, sponsored by University Hospitals Cleveland Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
Study Summary
1. The investigator hypothesize that the Laser pulpotomy will provide adequate and comparable success clinically in primary molars. 2. The investigators hypothesize that the Laser pulpotomy will provide adequate and comparable success radiographically in primary molars.
Primary Outcome
Failure is identified as radiographic: furcation radiolucency, external root resorption
Interventions
- PROCEDURE Formocresol application after pulpotomy preparation
- PROCEDURE GENTLEray 980 Soft Tissue diode laser
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2011-06 |
| Est. Completion | 2014-06 |
| Phase | NA |
Why NCT01622153 stopped before completion
NCT01622153 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 2 interventions - of which Formocresol application after pulpotomy preparation is the first listed.
NCT01622153 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01622153 about?
NCT01622153 is a clinical study titled "Electrical and Formocresol Pulpotomy in Primary Molars". 1. The investigator hypothesize that the Laser pulpotomy will provide adequate and comparable success clinically in primary molars. 2. The investigators hypothesize that the Laser pulpotomy will provide adequate and comparable success radiographically in primary molars.
What is the current status of trial NCT01622153?
This trial is currently terminated. It is a NA study. The enrollment target is 120 participants. The study started on 2011-06. Estimated completion is 2014-06.
What interventions are being tested in trial NCT01622153?
The interventions under investigation include: Formocresol application after pulpotomy preparation (PROCEDURE), GENTLEray 980 Soft Tissue diode laser (PROCEDURE).
Who is sponsoring clinical trial NCT01622153?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01622153's enrollment target sits among peer trials
120 762nd of 2000 higher than 1,198 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia